Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03501979
Brief Title: Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

First Submitted : April 8, 2018
First Submitted that Met QC Criteria : April 17, 2018
First Posted : April 18, 2018

Last Update Submitted that Met QC Criteria : July 20, 2021
Last Update Posted : July 22, 2021